Literature DB >> 25771005

Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology.

Marcelo C Ribeiro1, Leon G Tertoolen1, Juan A Guadix2, Milena Bellin1, Georgios Kosmidis1, Cristina D'Aniello1, Jantine Monshouwer-Kloots1, Marie-Jose Goumans3, Yu-Li Wang4, Adam W Feinberg5, Christine L Mummery1, Robert Passier6.   

Abstract

Cardiomyocytes from human pluripotent stem cells (hPSC-CM) have many potential applications in disease modelling and drug target discovery but their phenotypic similarity to early fetal stages of cardiac development limits their applicability. In this study we compared contraction stresses of hPSC-CM to 2nd trimester human fetal derived cardiomyocytes (hFetal-CM) by imaging displacement of fluorescent beads by single contracting hPSC-CM, aligned by microcontact-printing on polyacrylamide gels. hPSC-CM showed distinctly lower contraction stress than cardiomyocytes isolated from hFetal-CM. To improve maturation of hPSC-CM in vitro we made use of commercial media optimized for cardiomyocyte maturation, which promoted significantly higher contraction stress in hPSC-compared with hFetal-CM. Accordingly, other features of cardiomyocyte maturation were observed, most strikingly increased upstroke velocities and action potential amplitudes, lower resting membrane potentials, improved sarcomeric organization and alterations in cardiac-specific gene expression. Performing contraction force and electrophysiology measurements on individual cardiomyocytes revealed strong correlations between an increase in contraction force and a rise of the upstroke velocity and action potential amplitude and with a decrease in the resting membrane potential. We showed that under standard differentiation conditions hPSC-CM display lower contractile force than primary hFetal-CM and identified conditions under which a commercially available culture medium could induce molecular, morphological and functional maturation of hPSC-CM in vitro. These results are an important contribution for full implementation of hPSC-CM in cardiac disease modelling and drug discovery.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiomyocyte contraction force; Cardiomyocyte maturation; Human fetal cardiomyocytes; Human pluripotent stem cells

Mesh:

Year:  2015        PMID: 25771005     DOI: 10.1016/j.biomaterials.2015.01.067

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  90 in total

Review 1.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

Review 2.  Multi-Imaging Method to Assay the Contractile Mechanical Output of Micropatterned Human iPSC-Derived Cardiac Myocytes.

Authors:  Alexandre J S Ribeiro; Olivier Schwab; Mohammad A Mandegar; Yen-Sin Ang; Bruce R Conklin; Deepak Srivastava; Beth L Pruitt
Journal:  Circ Res       Date:  2017-04-11       Impact factor: 17.367

3.  Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes.

Authors:  Kavitha T Kuppusamy; Daniel C Jones; Henrik Sperber; Anup Madan; Karin A Fischer; Marita L Rodriguez; Lil Pabon; Wei-Zhong Zhu; Nathaniel L Tulloch; Xiulan Yang; Nathan J Sniadecki; Michael A Laflamme; Walter L Ruzzo; Charles E Murry; Hannele Ruohola-Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-11       Impact factor: 11.205

Review 4.  Three-dimensional scaffold-free microtissues engineered for cardiac repair.

Authors:  Alejandra Patino-Guerrero; Jaimeson Veldhuizen; Wuqiang Zhu; Raymond Q Migrino; Mehdi Nikkhah
Journal:  J Mater Chem B       Date:  2020-07-29       Impact factor: 6.331

Review 5.  High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.

Authors:  Genevieve Conant; Benjamin Fook Lun Lai; Rick Xing Ze Lu; Anastasia Korolj; Erika Yan Wang; Milica Radisic
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

Review 6.  In vitro models of the cardiac microenvironment to study myocyte and non-myocyte crosstalk: bioinspired approaches beyond the polystyrene dish.

Authors:  Celinda M Kofron; Ulrike Mende
Journal:  J Physiol       Date:  2017-02-27       Impact factor: 5.182

7.  Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.

Authors:  Gun-Sik Cho; Dong I Lee; Emmanouil Tampakakis; Sean Murphy; Peter Andersen; Hideki Uosaki; Stephen Chelko; Khalid Chakir; Ingie Hong; Kinya Seo; Huei-Sheng Vincent Chen; Xiongwen Chen; Cristina Basso; Steven R Houser; Gordon F Tomaselli; Brian O'Rourke; Daniel P Judge; David A Kass; Chulan Kwon
Journal:  Cell Rep       Date:  2017-01-10       Impact factor: 9.423

Review 8.  Evolution of strategies to improve preclinical cardiac safety testing.

Authors:  Gary Gintant; Philip T Sager; Norman Stockbridge
Journal:  Nat Rev Drug Discov       Date:  2016-02-19       Impact factor: 84.694

9.  Engineered Heart Muscle Models in Phenotypic Drug Screens.

Authors:  Wolfram-Hubertus Zimmermann
Journal:  Handb Exp Pharmacol       Date:  2021

10.  Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.

Authors:  Dongjian Hu; Annet Linders; Abir Yamak; Cláudia Correia; Jan David Kijlstra; Arman Garakani; Ling Xiao; David J Milan; Peter van der Meer; Margarida Serra; Paula M Alves; Ibrahim J Domian
Journal:  Circ Res       Date:  2018-10-12       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.